Teaching Course

14:00 - 14:30
Life-threatening headache: Non-vascular aetiologies

14:30 - 14:40
Discussion

14:40 - 15:10
Life-threatening headache: Vascular aetiologies

15:10 - 15:20
Discussion

15:20 - 15:50
Brain health and headache: Life-sustaining interventions

15:50 - 16:00
Discussion

14:00 - 14:25
Why, how, and when to prescribe exercises for patients with headaches

14:25 - 14:30
Discussion

14:30 - 14:55
Physical activity for the prevention of headache disorders

14:55 - 15:00
Discussion

15:00 - 15:25
The rationale of diet regulation on headache management

15:25 - 15:30
Discussion

15:30 - 15:55
Relaxation techniques

15:55 - 16:00
Discussion

14:00 - 14:20
CRISTINA TASSORELLI

14:20 - 14:40
VOLODYMYR ROMANENKO

14:40 - 15:00
RASHMI HALKER SINGH

15:00 - 15:20
ESME EKIZO?LU

15:20 - 15:40
BRONWYN JENKINS

15:40 - 16:00
MARCIO NATTAN

14:00 - 14:30
Overview of peripheral interventional treatments for headaches: Techniques and efficacy

14:30 - 15:00
Expanding access to peripheral nerve blocks: Addressing challenges and solutions

15:00 - 15:30
Botulinum toxin injections for chronic headaches: Clinical evidence and access barriers

15:30 - 16:00
The role of sphenopalatine ganglion (SPG) block and trigger point injections in headache management: Current practices and future directions

14:00 - 14:20
Acetaminophen

14:20 - 14:40
NSAIDs

14:40 - 15:00
Triptans and ditans

15:00 - 15:20
CGRP inhibitors

15:20 - 15:40
Neurotoxins

15:40 - 16:00
Lidocaine

14:00 - 14:40
Classification research. How to do it and use it

14:40 - 15:00
Research basis of chapter 4 diagnoses and future possibilities

15:20 - 15:40
Research basis of chapter 3 and the future of headache classification

15:40 - 16:00
Discussion

16:30 - 16:55
Fundamentals of clinical trial design: Key concepts and methodologies

16:55 - 17:00
Discussion

17:00 - 17:25
Innovative approaches in clinical trials: Adaptive designs and their applications

17:25 - 17:30
Discussion

17:30 - 17:55
Patient-centred outcomes in headache clinical trials: Measuring what matters

17:55 - 18:00
Discussion

18:00 - 18:25
Biomarkers and endpoints in headache trials: Challenges and opportunities

18:25 - 18:30
Discussion

16:30 - 16:55
Genetic models of migraine and how they might impact the lives of patients

16:55 - 17:00
Discussion

17:00 - 17:25
Innovations in pre-clinical neuroimaging using multiphoton microscopy and transgenic mice

17:25 - 17:30
Discussion

17:30 - 17:55
Defining functional brain networks using electrophysiology

17:55 - 18:00
Discussion

18:00 - 18:25
Chemogenetic manipulation of neuronal activity using small molecule ligand to activate synthetic G protein-coupled receptors and designer receptors exclusively activated by designer drugs (DREADDs)

18:25 - 18:30
Discussion

16:30 - 16:50
FREDA DODD GLOVER

16:50 - 17:10
TAKAO TAKESHIMA

17:10 - 17:30
YONG GANG WANG

17:30 - 18:00
Discussion

16:30 - 17:00
Implementing peripheral interventional treatments in diverse healthcare settings: Strategies for success

17:00 - 17:30
Policy and advocacy for expanding access to headache interventional treatments: Overcoming barriers

17:30 - 18:00
Break

18:00 - 18:30
Model-based practical applications for attenders

16:30 - 16:50
Amitriptyline (TCA)

16:50 - 17:10
Propranolol (beta blockers)

17:10 - 17:30
Topamax (anticonvulsant)

17:30 - 18:30
Discussion